Overview: Indian startups get fresh funding and more pitches

Ayurvedic tech startup NirogStreet has raised $12 million in Series B funding

NirogStreet, an ayurvedic technology platform in India, has secured $12 million in a Series B funding round led by Jungle Ventures.

It provides a community for Ayurvedic doctors and an e-commerce platform that streamlines the supply chain of Ayurvedic services and medicine. NirogStreet has included about 50,000 doctors and about 50 Ayurvedic brands.

The startup will use the proceeds from its latest investment round to strengthen its supply chain, technology and services.


Men’s health startup Bonatra receives pre-launch funding

Bonatra, an India-based men’s health startup, has raised INR 55 million ($670,000) in a pre-seed funding round led by ITI Growth Opportunities Fund with participation from marquee angel investors Jitendra Jagadev, founder of Nestaway, and Blackbuck founder Rajesh Yabaji.

The company runs a technology platform that offers personalized health programs targeting men’s chronic conditions.

In a statement, Bonatra said its new funding will be used to expand its offerings, build its team and grow its client base.


Edenlux introduces AI report to its eye health mobile app

South Korean medical device manufacturer Edenlux now provides AI-generated eye health management reports through its flagship mobile app Otus Plus.

The app allows users to test their eye health with a paired glasses device, do gamified eye exercises and receive an eye health report.

Its eye health reports now include AI-generated eye health scores, eye focus reaction speed analysis, and eye exercise game results based on user data.

In the future, Edenlux plans to add an improvement indicator to its reports, as well as offer a service that allows users to choose their own customized lenses for eye exercises and use the collected data to provide reports on eye health results.


Cha Vaccine ties up with MOGAM for AI drug discovery

The MOGAM Biomedical Research Institute has signed a memorandum of understanding with the Cha Vaccine Institute to discover anti-AI drugs.

They will collaborate to develop new drugs and improve medicinal substances using MOGAM’s AI algorithms, which will be tested using medical data from the Cha Vaccine. They will later conduct joint studies and apply for co-patents.